Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Abstract 2828: miR-19a-3p inhibits breast carcinoma metastasis via reversing M2 phenotype of TAMs.

Jian Yang, Na Li, Zhuhong Zhang, Qin Si, Chong Chen, Yan Liu, Ralph A. Reisfeld, Peiqing Sun, Dwayne Stupack, Rong Xiang, Yunping Luo

Cancer Res (2013) 73 (8_Supplement): 2828.

https://doi.org/10.1158/1538-7445.AM2013-2828

Published: 15 April 2013

View articletitled, Abstract 2828: miR-19a-3p inhibits breast carcinoma metastasis via reversing M2 phenotype of TAMs.

Journal Articles

Abstract 5614: Legumain protease substrate modified TAT-liposome cargo: an efficient tool for targeting malignant diseases.

Ze Liu, Min Xiong, Debbie Liao, Dan Lv, Ralph A. Reisfeld, Wolfgang Wrasidlo, Si Chen, Dwayne G. Stupack, Peiqing Sun, Xiaoyue Tan, Rong Xiang

Cancer Res (2013) 73 (8_Supplement): 5614.

https://doi.org/10.1158/1538-7445.AM2013-5614

Published: 15 April 2013

View articletitled, Abstract 5614: Legumain protease substrate modified TAT-liposome cargo: an efficient tool for targeting malignant diseases.

Journal Articles

Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Dan Lu, Si Chen, Xiaoyue Tan, Na Li, Chenghu Liu, Zongjin Li, Ze Liu, Dwayne G. Stupack, Ralph A. Reisfeld, Rong Xiang

Cancer Res (2012) 72 (14): 3451–3456.

https://doi.org/10.1158/0008-5472.CAN-11-2536

Published: 15 July 2012

View articletitled, Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Includes: Supplementary data

Journal Articles

Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating lymphocytes (TILs) and IC retention

Richard K. Yang, Nicholas A. Kalogriopoulos, Alexander L. Rakhmilevich, Erik A. Ranheim, Songwon Seo, KyungMann Kim, Kory L. Alderson, Jacek Gan, Ralph A. Reisfeld, Stephen D. Gillies, Jacquelyn A. Hank, Paul M. Sondel

Cancer Res (2012) 72 (8_Supplement): 1538.

https://doi.org/10.1158/1538-7445.AM2012-1538

Published: 15 April 2012

View articletitled, Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating lymphocytes (TILs) and IC retention

Journal Articles

Abstract 263: Silence of SOX2 induces apoptosis through both mitochondria and death receptor signal pathway by activating the RAS/MAPK signals in human lung cancer cells

Si Chen, Xuefei Li, Yingxi Xu, Lina Wang, Yanan Chen, Dan Lv, Ralph A. Reisfeld, Na Li, Rong Xiang

Cancer Res (2012) 72 (8_Supplement): 263.

https://doi.org/10.1158/1538-7445.AM2012-263

Published: 15 April 2012

View articletitled, Abstract 263: Silence of SOX2 induces apoptosis through both mitochondria and death receptor signal pathway by activating the RAS/MAPK signals in human lung cancer cells

Journal Articles

Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model

Debbie Liao, Ze Liu, Wolfgang J. Wrasidlo, Yunping Luo, Giang Nguyen, Tingmei Chen, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2011) 71 (17): 5688–5696.

https://doi.org/10.1158/0008-5472.CAN-11-1264

Published: 30 August 2011

View articletitled, Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model

Includes: Supplementary data

Journal Articles

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

David C. Delgado, Jacquelyn A. Hank, Jill Kolesar, David Lorentzen, Jacek Gan, Songwon Seo, KyungMann Kim, Suzanne Shusterman, Stephen D. Gillies, Ralph A. Reisfeld, Richard Yang, Brian Gadbaw, Kenneth B. DeSantes, Wendy B. London, Robert C. Seeger, John M. Maris, Paul M. Sondel

Cancer Res (2010) 70 (23): 9554–9561.

https://doi.org/10.1158/0008-5472.CAN-10-2211

Published: 06 December 2010

View articletitled, Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

Journal Articles

Abstract 1914: Cross-talk between breast cancer cells and tumor-associated macrophages leads to tumor cell invasion, angiogenesis and metastasis

Yun Ping Luo, Debbie Liao, Tsung-Hsien Chuang, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2010) 70 (8_Supplement): 1914.

https://doi.org/10.1158/1538-7445.AM10-1914

Published: 15 April 2010

View articletitled, Abstract 1914: Cross-talk between breast cancer cells and tumor-associated macrophages leads to tumor cell invasion, angiogenesis and metastasis

Journal Articles

Abstract 4232: Tumor-associated macrophages are responsible for EGF-R triggered upregulation of the Sox-2 signaling pathway in CSCs, which enhance tumorigenicity and tumor metastasis

Rong Xiang, Debbie Liao, Mei Ting Chen, Tsung-Hsien Chuang, Ralph A. Reisfeld, Yun Ping Luo

Cancer Res (2010) 70 (8_Supplement): 4232.

https://doi.org/10.1158/1538-7445.AM10-4232

Published: 15 April 2010

View articletitled, Abstract 4232: Tumor-associated macrophages are responsible for EGF-R triggered upregulation of the Sox-2 signaling pathway in CSCs, which enhance tumorigenicity and tumor metastasis

Journal Articles

Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Yan Zeng, Nicole Huebener, Stefan Fest, Silke Weixler, Ulrike Schroeder, Gerhard Gaedicke, Rong Xiang, Alexander Schramm, Angelika Eggert, Ralph A. Reisfeld, Holger N. Lode

Cancer Res (2007) 67 (5): 2331–2338.

https://doi.org/10.1158/0008-5472.CAN-06-3041

Published: 01 March 2007

View articletitled, Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Journal Articles

Microarray analyses of putative breast cancer stem cells

Charles D. Kaplan, Joerg Krueger, He Zhou, Yunping Luo, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2006) 66 (8_Supplement): 239–240.

Published: 15 April 2006

View articletitled, Microarray analyses of putative breast cancer stem cells

Journal Articles

Breast cancer and neuroblastoma models for the in vivo study of stem cell like cancer cells in immune competent mice

Joerg A. Krueger, Charles D. Kaplan, Yunping Luo, He Zhou, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2006) 66 (8_Supplement): 240.

Published: 15 April 2006

View articletitled, Breast cancer and neuroblastoma models for the in vivo study of stem cell like cancer cells in immune competent mice

Journal Articles

Induction of tumor-specific T cell memory by a genomic immunization targeting Fos-related Antigen 1

Yunping Luo, He Zhou, Masato Mizutani, Noriko Mizutani, Noriko Mizutani, Ralph A. Reisfeld, Rong Xiang

Cancer Res (2006) 66 (8_Supplement): 334.

Published: 15 April 2006

View articletitled, Induction of tumor-specific T cell memory by a genomic immunization targeting Fos-related Antigen 1

Journal Articles

Targeting tumor-associated macrophages: A novel strategy against breast cancer.

Yunping Luo, He Zhou, Joerg A. Krueger, Charles D. Kaplan, Carrie Dolman, Dorothy Markowitz, Wenyuan Wu, Cheng Liu, Ralph A. Reisfeld, Rong Xiang

Cancer Res (2006) 66 (8_Supplement): 1307.

Published: 15 April 2006

View articletitled, Targeting tumor-associated macrophages: A novel strategy against breast cancer.

Journal Articles

A DNA-based cancer vaccine enhances lymphocyte crosstalk by engaging the NKG2D receptor

He Zhou, Yunping Luo, Charles D. Kaplan, Joerg A. Krueger, Sung-Hyung Lee, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2006) 66 (8_Supplement): 940.

Published: 15 April 2006

View articletitled, A DNA-based cancer vaccine enhances lymphocyte crosstalk by engaging the NKG2D receptor

Journal Articles

Immunostimulatory Effects of Low-Dose Cyclophosphamide Are Controlled by Inducible Nitric Oxide Synthase

Markus Loeffler, Jörg A. Krüger, Ralph A. Reisfeld

Cancer Res (2005) 65 (12): 5027–5030.

https://doi.org/10.1158/0008-5472.CAN-05-0646

Published: 15 June 2005

View articletitled, Immunostimulatory Effects of Low-Dose Cyclophosphamide Are Controlled by Inducible Nitric Oxide Synthase

Journal Articles

A DNA vaccine against tumor stromal antigen FAP boosts chemotherapy leading to tumor rejection

Joerg A. Krueger, Markus Loeffler, Andreas Niethammer, Ralph A. Reisfeld

Cancer Res (2005) 65 (9_Supplement): 1453.

Published: 01 May 2005

View articletitled, A DNA vaccine against tumor stromal antigen FAP boosts chemotherapy leading to tumor rejection

Journal Articles

Endoglin(CD105) is an effective target for an oral DNA vaccine against breast cancer

Sung-Hyung Lee, Noriko Mizutani, Yunping Luo, He Zhou, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2005) 65 (9_Supplement): 1453.

Published: 01 May 2005

View articletitled, Endoglin(CD105) is an effective target for an oral DNA vaccine against breast cancer

Journal Articles

A DNA-based cancer vaccine activates both innate and adaptive immunity by engaging the NKG2D receptor

He Zhou, Yunping Luo, Jeng-Fan Lo, Masato Mizutani, Noriko Mizutani, Rong Xiang, Ralph A. Reisfeld

Cancer Res (2005) 65 (9_Supplement): 1216.

Published: 01 May 2005

View articletitled, A DNA-based cancer vaccine activates both innate and adaptive immunity by engaging the NKG2D receptor

Journal Articles

A novel stress protein, legumain, is a target for a genetic vaccine against breast cancer

Yunping Luo, He Zhou, Chen Liu, Sung-Hyung Lee, Rong Xinag, Ralph A. Reisfeld

Cancer Res (2005) 65 (9_Supplement): 1216–1217.

Published: 01 May 2005

View articletitled, A novel stress protein, legumain, is a target for a genetic vaccine against breast cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 2828: miR-19a-3p inhibits breast carcinoma metastasis via reversing M2 phenotype of TAMs.

Abstract 5614: Legumain protease substrate modified TAT-liposome cargo: an efficient tool for targeting malignant diseases.

Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Abstract 1538: Enhanced antitumor effects of intratumoral (IT) hu14.18-IL2 immunocytokine (IC) compared to intravenous (IV) hu14.18-IL2 are distinguished by increased activated tumor infiltrating lymphocytes (TILs) and IC retention

Abstract 263: Silence of SOX2 induces apoptosis through both mitochondria and death receptor signal pathway by activating the RAS/MAPK signals in human lung cancer cells

Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

Abstract 1914: Cross-talk between breast cancer cells and tumor-associated macrophages leads to tumor cell invasion, angiogenesis and metastasis

Abstract 4232: Tumor-associated macrophages are responsible for EGF-R triggered upregulation of the Sox-2 signaling pathway in CSCs, which enhance tumorigenicity and tumor metastasis

Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Microarray analyses of putative breast cancer stem cells

Breast cancer and neuroblastoma models for the in vivo study of stem cell like cancer cells in immune competent mice

Induction of tumor-specific T cell memory by a genomic immunization targeting Fos-related Antigen 1

Targeting tumor-associated macrophages: A novel strategy against breast cancer.

A DNA-based cancer vaccine enhances lymphocyte crosstalk by engaging the NKG2D receptor

Immunostimulatory Effects of Low-Dose Cyclophosphamide Are Controlled by Inducible Nitric Oxide Synthase

A DNA vaccine against tumor stromal antigen FAP boosts chemotherapy leading to tumor rejection

Endoglin(CD105) is an effective target for an oral DNA vaccine against breast cancer

A DNA-based cancer vaccine activates both innate and adaptive immunity by engaging the NKG2D receptor

A novel stress protein, legumain, is a target for a genetic vaccine against breast cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only